Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory
暂无分享,去创建一个
Kenneth D. Doig | K. Doig | A. Fellowes | D. Westerman | P. Blombery | C. Forsyth | R. Agarwal | Kate Jones | M. McBean